Vistagen Therapeutics, Inc. Common Stock (VTGN) is a publicly traded Healthcare sector company. As of July 31, 2026, VTGN trades at $0.24 with a market cap of $9.98M and a P/E ratio of -0.13. VTGN moved +0.00% today. Year to date, VTGN is -64.51%; over the trailing twelve months it is -91.83%. Its 52-week range spans $0.20 to $5.14. Analyst consensus is neutral with an average price target of $1.00. Rallies surfaces VTGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks VTGN insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $0.24 |
| Market Cap | $9.98M |
| P/E Ratio | -0.13 |
| EPS | $-1.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.14 |
| 52-Week Low | $0.20 |
| Volume | 153.69K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.27M |
| Net Income | $-69.69M |
| Gross Margin | 0.00% |
2 analysts cover VTGN: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $1.00.